台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    28.35
  • 漲跌
    ▼0.30
  • 漲幅
    -1.05%
  • 成交量
    1,105
  • 產業
    上市 生技醫療類股
  • 302人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
神隆 (1789)籌碼相關-統一-新店 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

統一-新店 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2019/05/2900.00225.6525.55-2369-0.54%
2019/05/2400.00824.5025.10-8362-2.21%
2019/04/09226.4500.0026.5525520.36%
2019/03/26126.50126.3526.3005250.00%
2019/03/22126.70126.6026.5505190.00%
2019/02/15227.5500.0027.3026610.30%
2019/01/2800.00327.1026.80-3658-0.46%
2019/01/23226.8000.0027.3526510.31%
2019/01/220.926.5000.0026.600.96460.14%
2018/12/1300.000.725.9025.90-0.7638-0.10%
2018/11/21427.18426.5527.0006090.00%
2018/11/0900.00223.8324.10-2510-0.39%
2018/10/0800.00529.5029.35-5452-1.10%
2018/10/01530.7000.0030.6054581.09%
2018/09/1900.00131.2531.30-1463-0.22%
2018/08/1000.00232.5032.00-2667-0.30%
2018/08/03232.60232.3532.3506670.00%
2018/07/1800.00132.8033.15-1662-0.15%
2018/07/12132.3000.0032.4016640.15%
2018/07/0900.00232.2532.20-2672-0.30%
2018/06/2100.00332.7532.70-3812-0.37%
2018/06/19132.65132.8532.6508230.00%
2018/06/1500.00133.4032.40-1825-0.12%
2018/06/05134.2016.834.5934.30-15.8790-2.00%
2018/06/04133.95133.8533.8507760.00%
2018/06/01234.40233.9533.9507780.00%
2018/05/2800.00133.3532.85-1733-0.14%
2018/05/25133.2500.0033.0517330.14%
2018/05/2400.002033.0533.70-20724-2.76%
2018/05/152532.5500.0032.40257173.49%
2018/05/04132.20131.9531.7507930.00%
2018/04/091534.8700.0034.90159901.51%
2018/04/02334.3500.0033.9039820.31%
2018/03/19133.00133.0032.9509060.00%
2018/03/16133.20133.1533.1509200.00%
2018/02/0700.00531.9031.35-51,079-0.46%
2018/02/0600.0020731.4531.00-2071,094-18.92% 大賣/鉅額交易
2018/01/3000.00434.9034.85-41,345-0.30%
2018/01/16236.1500.0036.0521,3300.15%
2018/01/15636.53436.7036.7021,2970.15%
2018/01/053235.5200.0035.70321,2162.63%
2018/01/041035.751035.8535.8501,2120.00%
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章